These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26788152)

  • 1. JAK/STAT3 signaling pathway mediates endothelial-like differentiation of immature dendritic cells.
    Jin G; Zhao J; Yang YI; Liu K; Jiang Y; Zhang X; Zhang Y; Huang Y; Lu J; Dong Z
    Oncol Lett; 2015 Dec; 10(6):3471-3477. PubMed ID: 26788152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAPK/ERK1/2 signaling mediates endothelial-like differentiation of immature DCs in the microenvironment of esophageal squamous cell carcinoma.
    Lu J; Zhao J; Liu K; Zhao J; Yang H; Huang Y; Qin Z; Bai R; Li P; Ma J; Yan W; Zhao M; Dong Z
    Cell Mol Life Sci; 2010 Jun; 67(12):2091-106. PubMed ID: 20221785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of immature DCs into endothelial-like cells in human esophageal carcinoma tissue homogenates.
    Lu J; Bai R; Qin Z; Zhang Y; Zhang X; Jiang Y; Yang H; Huang Y; Li G; Zhao M; Dong Z
    Oncol Rep; 2013 Aug; 30(2):739-44. PubMed ID: 23708958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-A-induced immature DCs not mature DCs differentiation into endothelial-like cells through ERK1/2-dependent pathway.
    Lu J; Zhao J; Zhao J; Ma J; Liu K; Yang H; Huang Y; Qin Z; Bai R; Li P; Yan W; Zhao M; Dong Z
    Cell Biochem Funct; 2011 Jun; 29(4):294-302. PubMed ID: 21520151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
    Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
    Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF-A not Ang2 mediates endothelial-like differentiation of immature DCs by ERK1/2 signaling in the microenvironment of human colon adenocarcinoma.
    Lu J; Liu K; Zhao J; Zhao J; Ma J; Yang H; Huang Y; Qin Z; Bai R; Jiang L; Lv F; Li P; Yan W; Zhao M; Dong Z
    Int J Oncol; 2011 Jun; 38(6):1579-88. PubMed ID: 21455573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of p-Stat3 and Mcl-1, and their correlation with differentiation and apoptotic resistance in esophageal squamous cell carcinoma].
    Huo YQ; Ruan X; DU XL; Shang L; Cai Y; Xu X; Wang MR; Zhang Y; Fu SB
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):579-84. PubMed ID: 24314214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.
    Zitman-Gal T; Einbinder Y; Ohana M; Katzav A; Kartawy A; Benchetrit S
    J Diabetes; 2019 Aug; 11(8):656-664. PubMed ID: 30575282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fer is a downstream effector of insulin and mediates the activation of signal transducer and activator of transcription 3 in myogenic cells.
    Taler M; Shpungin S; Salem Y; Malovani H; Pasder O; Nir U
    Mol Endocrinol; 2003 Aug; 17(8):1580-92. PubMed ID: 12738762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingnaoyizhi decoction suppresses the formation of glial fibrillary acidic protein-positive cells in cultured neural stem cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
    Wu Y; Jing Z; Qin X; Zhou Z; Wang K; Song W; Wang X; Hou M; Zhang Y; Kang L
    J Tradit Chin Med; 2015 Feb; 35(1):69-76. PubMed ID: 25842731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells.
    Coppo P; Flamant S; De Mas V; Jarrier P; Guillier M; Bonnet ML; Lacout C; Guilhot F; Vainchenker W; Turhan AG
    Br J Haematol; 2006 Jul; 134(2):171-9. PubMed ID: 16846476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.
    Bharadwaj U; Kasembeli MM; Robinson P; Tweardy DJ
    Pharmacol Rev; 2020 Apr; 72(2):486-526. PubMed ID: 32198236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
    Wu MH; Chen XY; Cai KR
    Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term fibronectin treatment induces endothelial-like and angiogenic properties in monocyte-derived immature dendritic cells: involvement of intracellular VEGF and MAPK regulation.
    Berger S; Dyugovskaya L; Polyakov A; Lavie L
    Eur J Cell Biol; 2012 Aug; 91(8):640-53. PubMed ID: 22475441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
    Liu J; Kern JA
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth.
    Song M; Yoon G; Choi JS; Kim E; Liu X; Oh HN; Chae JI; Lee MH; Shim JH
    Phytother Res; 2020 Aug; 34(8):2032-2043. PubMed ID: 32144852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct compartmental distribution of mature and immature dendritic cells in esophageal squamous cell carcinoma.
    Liu J; Lu G; Li Z; Tang F; Liu Y; Cui G
    Pathol Res Pract; 2010 Sep; 206(9):602-6. PubMed ID: 20547010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
    Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
    Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
    Wang L; Kurosaki T; Corey SJ
    Oncogene; 2007 May; 26(20):2851-9. PubMed ID: 17146444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.